Involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of bis selenide in the mouse tail suspension test

European Journal of Pharmacology

Volumn 635, Issue 1-3, 2010, Pages 135-141

  Jesse, Cristiano R ^a   Wilhelm, Ethel A ^a   Bortolatto, Cristiani F ^a   Rocha, João B T ^a   Nogueira, Cristina W ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

Author keywords

Antidepressant; Bis selenide; Cyclic guanosine monophosphate; Immobility; Oxide nitric; Selenium

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 7 NITROINDAZOLE; ANTIDEPRESSANT AGENT; ARGININE; BIS SELENIDE; CYCLIC GMP; METHYLENE BLUE; N ACETYL S NITROSOPENICILLAMINE; N(G) NITROARGININE; NITRATE; NITRIC OXIDE; NITRITE; SILDENAFIL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; DRUG STRUCTURE; EX VIVO STUDY; EXPERIMENTAL TEST; FORCED SWIMMING TEST; IMMOBILIZATION; MALE; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TAIL SUSPENSION TEST;

EID: 84984568120     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.03.019     Document Type: Article

References (44)

1. Almeida R.C., Felisbino C.S., López M.G., Rodrigues A.L.S., Gabilan N.H. Evidence for the involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of memantine in mice. Behav. Brain Res. 2006, 168:318-322.
2. Barbey J.T., Roose S.P. SSRI: safety in overdose. J. Clin. Psychiatry 1998, 59:42-59.
3. Beavo J.A. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol. Rev. 1995, 75:725-748.
4. Bourin M., Chenu F., Ripoll N., David D.J.P. A proposal of decision tree to screen putative antidepressants using forced swim and tail suspensions tests. Behav. Brain Res. 2005, 164:266-269.
5. Bourin M., Chenu F., Prica C., Hascoët M. Augmentation effect of combination therapy of aripiprazole and antidepressants of forced swimming test in mice. Psychopharmacology 2009, 206:97-107.
6. Brocardo P.S., Budni J., Lobato K.R., Kaster M.P., Rodrigues A.L.S. Antidepressant-like effect of folic acid: involvement of NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway. Eur. J. Pharmacol. 2008, 598:37-42.
7. Cryan J.F., Markou A., Lucki I. Assessing antidepressant activity in rodents: recent developments and future needs. Trends Pharmacol. Sci. 2002, 23:238-245.
8. Cunha M.P., Machado D.G., Bettio L.E.B., Capra J.C., Rodrigues A.L.S. Interaction of zinc with antidepressants in the tail suspension test. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1913-1920.
9. Da Silva G.D., Matteussi A.S., Santos A.R.S., Calixto J.B., Rodrigues A.L.S. Evidence for dual effects of nitric oxide in the forced swimming test and in the tail suspension test in mice. Neuroreport 2000, 11:3699-3702.
10. D'Aquila P.S., Collu M., Gessa G.L., Serra G. The role of dopamine in the mechanism of action of antidepressant drugs. Eur. J. Pharmacol. 2000, 405:365-373.
11. Dhir A., Kulkarni S.K. Involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:921-925.
12. Elhwuegi A.S. Central monoamines and their role in major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2004, 28:435-451.
13. Ergün Y., Ergün U.G. Prevention of pro-depressant effect of l-arginine in the forced swim test by NG-nitro-l-arginine an [1H-[1, 2, 4]Oxadiazole[4, 3-a]quinoxalin-1-one]. Eur. J. Pharmacol. 2007, 554:150-154.
14. Eroglu L., Caglayan B. Anxiolytic and antidepressant properties of methylene blue in animal models. Pharmacol. Res. 1997, 36:381-385.
15. Harkin A.J., Connor T.J., Burns M.P., Kelly J.P. Nitric oxide synthase inhibitors augment the effects of serotonin reuptake inhibitors in the forced swimming test. Eur. Neuropsychopharmacol. 2004, 14:274-281.
16. Hawkes W.C., Hornbostel L. Effects of dietary selenium on mood in healthy men living in a metabolic research unit. Biol. Psychiatry 1996, 39:121-128.
17. Heiberg I.L., Wegener G., Rosenberg R. Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats. Behav. Brain Res. 2002, 134:479-484.
18. Jabbari B., Bryan G.E., Marsh E.E., Gunderson C.H. Incidence of seizures with tricyclic and tetracyclic antidepressants. Arch. Neurol. 1985, 42:480-481.
19. Jesse C.R., Savegnago L., Nogueira C.W. Role of nitric oxide/cyclic GMP/K+ channel pathways in the antinociceptive effect caused by 2, 3-bis(mesitylseleno)propenol. Life Sci. 2007, 81:1694-1702.
20. Jesse C.R., Savegnago L., Nogueira C.W. Spinal mechanisms of antinociceptive effect caused by oral administration of bis selenide in mice. Brain Res. 2008, 1231:25-33.
21. Jesse C.R., Bortolatto C.F., Savegnago L., Rocha J.B.T., Nogueira C.W. Involvement of l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tramadol in the rat forced swimming test. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1838-1843.
22. Kaehler S.T., Singewald N., Sinner C., Philippu A. Nitric oxide modulates the release of serotonin in the rat hypothalamus. Brain Res. 1999, 835:346-349.
23. Kaster M.P., Rosa A.O., Santos A.R.S., Rodrigues A.L.S. Involvement of nitric oxide-cGMP pathway in the antidepressant-like effects of adenosine in the forced swimming test. Int. J. Neuropsychopharmacol. 2005, 8:601-606.
24. Kulkarni S.K., Dhir A. Possible involvement of l-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride. Eur. J. Pharmacol. 2007, 569:77-83.
25. Lorrain D.S., Hull E.M. Nitric oxide increases dopamine and serotonin release in the medial preoptic area. Neuroreport 1993, 5:87-89.
26. Miranda K.M., Espey M.G., Wink D.A. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001, 5:62-71.
27. Moro A.V., Nogueira C.W., Barbosa N.B.V., Menezes P.H., Rocha J.B.T., Zeni G. Highly stereoselective one-pot producers to prepare bis- and tris chalcogenide alkenes via addition of disulfides and diselenides to terminal alkynes. J. Org. Chem. 2005, 70:5257-5268.
28. Murray C.J., Lopez A.D. Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 1997, 349:1436-1442.
29. Palucha A., Pilc A. On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressant. Pol. J. Pharmacol. 2002, 54:581-586.
30. Papakostas G.I. Dopaminergic-based pharmacotherapies for depression. Eur. Neuropsychopharmacol. 2006, 16:391-402.
31. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
32. Posser T., Kaster M.P., Baraúna S.C., Rocha J.B.T., Rodrigues A.L.S., Leal R.B. Antidepressant-like effect of the organoselenium compound ebselen in mice: evidence for the involvement of the monoaminergic system. Eur. J. Pharmacol. 2009, 602:85-91.
33. Rayman M.P. The importance of selenium to human health. Lancet 2000, 356:23-41.
34. Rodrigues A.L.S., Da Silva G.L., Mateussi A.S., Fernandes E.S., Miguel O.G., Yunes R.A. Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus. Life Sci. 2002, 70:1347-1358.
35. Savegnago L., Jesse C.R., Moro A.V., Borges V.C., Santos F.W., Rocha J.B.T., Nogueira C.W. Bis selenide alkene derivatives: a class of potential antioxidant and antinociceptive agents. Pharmacol. Biochem. Behav. 2006, 83:221-229.
36. Savegnago L., Jesse C.R., Pinto L.G., Rocha J.B.T., Nogueira C.W., Zeni G. Monoaminergic agents modulate antidepressant-like effect caused by diphenyl diselenide in rats. Prog. Neuropsychopharmacol. Biol. Psychiatry 2007, 31:1261-1269.
37. Savegnago L., Jesse C.R., Pinto L.G., Rocha J.B.T., Barancelli D.A., Nogueira C.W., Zeni G. Diphenyl diselenide exerts antidepressant-like and anxiolytic-like effects in mice: involvement of 1-arginine-nitric oxide-soluble guanylate cyclase pathway in its antidepressent-like action. Pharmacol. Biochem. Behav. 2008, 88:418-426.
38. Smith J.C., Whitton P.S. Nitric oxide modulates N-methyl-daspartate-evoked serotonin release in the raphe nuclei and frontal cortex of the freely moving rat. Neurosci. Lett. 2000, 291:5-8.
39. Snyder S.H. Biosensors. NO release for good measure. Nature 1992, 358:623.
40. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985, 85:367-370.
41. Tournier M., Grolleau A., Cougnard A., Molimard M., Verdoux H. Factors associated with choice of psychotropic drugs used for intentional drug overdose. Eur. Arch. Psychiatry Clin. Neurosci. 2009, 259:86-91.
42. Volke V., Wegener G., Bourin M., Vasar E. Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice. Behav. Brain Res. 2003, 140:141-147.
43. White N., Litovitz T., Clancy C. Suicidal antidepressant overdoses: a comparative analysis of antidepressant type. J. Med. Toxicol. 2008, 4:238-250.
44. Yildiz F., Erden B.F., Ulak G., Utkan T., Gacar N. Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats. Psychopharmacology 2000, 149:41-44.